Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DonnaMega
NCT02760472Phase 3Completed
- Start
- Mar 2013
- Primary completion
- Sep 2015
- Modality
- Lipid-based Nanoparticles
01
Overview
A Phase 3 trial of SMOFlipid in retinopathy of prematurity (ROP). Started Mar 2013; status: completed.
02
Drugs
SMOFlipid
03
Conditions
retinopathy of prematurity (ROP)
Beyond the preview
Go deeper on NCT02760472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02760472.